4
Changes in Ownership
CYTOKINETICS INC Filed Acc 0001127602-24-022909
Director sold 5,000 shares at $57.26 ($286,300)
- Director acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
PARSHALL B LYNNE · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-26 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,000 | $21.61 | $108,050 | 25,600 | D |
| 2024-08-26 | Sale : show line 2 in the form 10b5-1 | −5,000 | $57.26 | $286,300 | 20,600 | D |
| Open-market sales · 5,000 sh · avg $57.26 · $286,300 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-26 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (Right to Buy) | −5,000 | 5,000 | D |
Loading xslF345X05/form4.xml…